Oxymorphone IR

DRUG3 trials

Sponsors

Endo Pharmaceuticals

Conditions

Chronic PainPost-operative PainPostoperative Pain

Phase 3

Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.

CompletedNCT00801398

Endo PharmaceuticalsPostoperative Pain

Start: 2009-02-17End: 2011-04-18Updated: 2019-02-27

Post-operative Efficacy and Safety Study

CompletedNCT00904085

Endo PharmaceuticalsPost-operative Pain

Start: 2003-04-30End: 2003-06-30Updated: 2010-02-15

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

WithdrawnNCT01206907

Endo PharmaceuticalsChronic Pain

Start: 2010-10-31End: 2013-12-31Updated: 2012-08-17